To The Moon

$Gilead Sciences(GILD)$

$Gilead Sciences (GILD) Closed +0.40% at $138.92 — Momentum Building Toward $145.33 Resistance, Breakout Watch Active

Latest Close Data: GILD settled at $138.92 (+0.40%) on Aug 18, trading within a tight range of $136.63–$139.49. The stock remains 11.7% below its 52-week high of $157.29, but is now only 4.4% away from the immediate resistance at $145.33.

Core Market Drivers: Biotech sentiment firmed as investors rotated into defensive healthcare names. GILD's Trodelvy pipeline optimism and dividend yield of 2.32% continue to attract income-focused capital. Recent Barclays PT cut to $145 was absorbed without major damage, suggesting accumulation near support.

Technical Analysis: Volume was moderate at 3.94M shares (VR 0.75) — not explosive, but supportive. MACD is bullish: DIF 1.83 > DEA 1.18, with positive histogram expansion (1.31). RSI(6) at 75.83 signals short-term overbought, while RSI(12) at 64.73 remains healthy. KDJ J-value spiked to 111.9, hinting at possible near-term pullback before continuation.

Key Price Levels:

• Primary Support: $129.52 (Aug 14 swing low)

• Strong Resistance: $145.33 (prior breakdown level)

• Immediate Pivot: $138.36 (yesterday's close, now intraday anchor)

Valuation Perspective: Forward P/E is deeply negative at -312 due to recent impairments; P/S at 5.66 and P/B at 14.57 reflect premium biotech valuation. Dividend yield of 2.32% offers downside cushion.

Analyst Targets: 27 analysts with average target of $157.79 (range $123–$180). Ratings: 7 Strong Buy, 18 Buy, 6 Hold — consensus remains constructive despite recent downgrades.

Weekly Outlook: Expect range-bound digestion between $136.50–$145.30. A daily close above $145.33 opens path to $152, then $157. A break below $129.50 would negate bullish structure and target $124.

⚠️ Technical analysis only — not investment advice. Biotech volatility and binary pipeline catalysts create asymmetric risk.

🎯$Gilead Sciences (GILD) Options Strategy: Bull Call Spread (Vertical Debit Spread)

• Underlying: GILD (Gilead Sciences)

• View: Cautiously bullish — momentum building toward $145.33 resistance, but RSI(6) at 75.83 and KDJ J-value at 111.9 suggest short-term overbought risk. A defined-risk debit spread captures upside while limiting exposure to a pullback.

• Strategy Type: Bull Call Spread (Debit Spread / Directional Long)

• Option Contract Portfolio:

  • Buy 1x GILD 2026-08-28 140 Call @ $1.605 (mid)

  • Sell 1x GILD 2026-08-28 145 Call @ $1.470 (mid)

• Max Gain & Loss:

  • Max Gain: $365 per spread = ($145 - $140 - $0.135) × 100

  • Max Loss: $13.5 per spread = ($1.605 - $1.470) × 100

• Initial Cost (Debit): $0.135 per spread ($13.5 per contract pair)

🐯🪙 Share your choice and reasoning in the comments — thoughtful views may receive Tiger Coins!

Good allocation isn’t just about investing — it’s also about keeping everyday life organised.

Just like a well-balanced portfolio, the right organisation can make business trips, travel and workouts a little easier. The new Tiger Toiletry Bag features a dual-layer dry & wet separation design with plenty of space to keep your essentials neatly organised, wherever you go.

Redeem the new Tiger Toiletry Bag now in Tiger Coin Mall. https://laohu8.com/J/redeemGift?goodID=100538&type=delivery